RBC Capital Markets increased its price target on Celestica (NYSE:CLS) shares from $115.00 to $140.00 while maintaining an Outperform rating. Currently trading at $131.66, near its 52-week high, ...

BMO Capital Markets increased its price target on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares, moving the ...

RBC Capital Markets upgraded Bank of Montreal (NYSE:BMO) and Canadian Imperial Bank of Commerce (NYSE:CM) to Outperform from Sector Perform in a recent note, as analyst Darko Mihelic sees a ...

RBC Capital analyst Darko Mihelic upgraded Bank of Montreal (BMO) to Outperform from Sector Perform with a C$161 price target up from C$133 prior. The company is likely past its credit concerns ...

Jan 13 (Reuters) - BMO Capital Markets (BMO.TO), opens new tab agreed to pay more than $40 million to settle U.S. Securities and Exchange Commission charges it failed to properly supervise ...

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

In a report released on January 27, Michael Siperco from RBC Capital maintained a Buy ... In a report released on January 23, BMO Capital also assigned a Buy rating to the stock with a C$15. ...

Bank of Montreal (BMO.TO)(BMO) shares rose on Wednesday after RBC Capital Markets hiked its price target by over 20 per cent, while boosting its rating on the stock to “Outperform.” BMO shares fell in ...

DuPont de Nemours (NYSE:DD – Get Free Report) had its target price dropped by research analysts at BMO Capital Markets from $107.00 to $105.00 in a research note issued to investors on ...